Viewing Study NCT05905458


Ignite Creation Date: 2025-12-25 @ 12:19 AM
Ignite Modification Date: 2026-04-15 @ 3:32 AM
Study NCT ID: NCT05905458
Status: COMPLETED
Last Update Posted: 2024-12-03
First Post: 2023-06-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase II Clinical Study of the Efficacy and Safety of HRS9950 Tablets in Chronic Hepatitis B Patients Who Are Virologically Suppressed on Nucleoside or Nucleotide Analogues (NAs)
Sponsor: Chengdu Suncadia Medicine Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module